James Mulshine to Clinical Trials as Topic
This is a "connection" page, showing publications James Mulshine has written about Clinical Trials as Topic.
Connection Strength
0.247
-
The Liverpool Statement 2005: priorities for the European Union/United States spiral computed tomography collaborative group. J Thorac Oncol. 2006 Jun; 1(5):497-8.
Score: 0.061
-
The potential contributions of chronic inflammation to lung carcinogenesis. Clin Lung Cancer. 2003 Jul; 5(1):46-62.
Score: 0.049
-
IV international conference on prevention and early detection of lung cancer, Reykjavik, Iceland, August 9-12, 2001. Lung Cancer. 2002 Sep; 37(3):325-44.
Score: 0.047
-
Need for uniformity in collection and reporting of data in cancer clinical trials. J Natl Cancer Inst. 1990 Sep 05; 82(17):1377-8.
Score: 0.020
-
Autocrine growth factors as therapeutic targets in lung cancer. Chest. 1989 Jul; 96(1 Suppl):31S-34S.
Score: 0.019
-
Clinical use of a monoclonal antibody to bombesin-like peptide in patients with lung cancer. Ann N Y Acad Sci. 1988; 547:360-72.
Score: 0.017
-
Treatment of non-small-cell lung cancer. J Clin Oncol. 1986 Nov; 4(11):1704-15.
Score: 0.016
-
Lung cancer screening by spiral CT. What is the optimal target population for screening trials? Lung Cancer. 2002 Dec; 38(3):243-52.
Score: 0.012
-
Primary and Secondary Prevention of Lung Cancer: an International Association for the Study of Lung Cancer workshop. Lung Cancer. 1995 Mar; 12(1-2):91-103.
Score: 0.007